Stellar-002: A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination With Immuno-Oncology Agents in Subjects With Unresectable Advanced or Metastatic Solid Tumors
Condition: Non-small Cell Lung Cancer, Prostate Cancer, Renal Cancer, Liver Cancer, Head & Neck Cancer
